A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

R. Gacesa, A.V. Vila, V. Collij, Z. Mujagic, A. Kurilshikov, M.D. Voskuil, E.A.M. Festen, C. Wijmenga, D.M.A.E. Jonkers, G. Dijkstra, J. Fu, A. Zhernakova, F. Imhann*, R.K. Weersma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1943288
Number of pages18
JournalGut Microbes
Volume13
Issue number1
DOIs
Publication statusPublished - 1 Jan 2021

Keywords

  • Gut microbiome
  • inflammatory bowel disease
  • biomarkers
  • human beta defensin 2
  • noninvasive diagnosis
  • machine learning
  • CHROMOGRANIN-A
  • INTRAINDIVIDUAL VARIABILITY
  • HUMAN BETA-DEFENSIN-2
  • MICROBIOME
  • BIOMARKER
  • MARKERS
  • PLASMA
  • INDEX

Cite this